Treatment of asymptomatic Endameba histolytica carriers with a formulation of bacitracin methylene disalicylate and iodochlorhydroxyquin (anameba).
D000562:Amebiasis / Q000628:therapy*; D001414:Bacitracin / Q000628:therapy*; D007464:Clioquinol / Q000628:therapy*; D004748:Entamoeba histolytica; D006579:Heterozygote; D012459:Salicylates
D012459:Salicylates; D001414:Bacitracin; D007464:Clioquinol; C023400:bacitracin methylenedisalicylic acid
AMEBIASIS/therapy; BACITRACIN/therapy; IODOCHLORHYDROXYQUIN/therapy